Aggressive Lipid-Lowering Initiation Abates New Cardiac Events - ALLIANCE


The goal of the trial was to evaluate the effect of an aggressive lipid-lowering program using atorvastatin compared with usual care on cardiovascular events in patients with a history of coronary artery disease (CAD) and elevated low-density lipoprotein (LDL) levels in a managed care population.